All posts tagged in which may have violated China’s privacy laws. This probe comes amidst Beijing’s broader anti-corruption campaign in the pharmaceutical and healthcare sectors

In a significant development for the pharmaceutical giant AstraZeneca, Chinese authorities have reportedly detained five current and former employees as part of an investigation into potential breaches of data privacy